Medical Monitoring Provider Dexcom's Stock Drops 40% as Q2 Revenue Misses Estimates, Lowers Full-Year Guidance

Medical Monitoring Provider Dexcom's Stock Drops 40% as Q2 Revenue Misses Estimates, Lowers Full-Year Guidance

Medical Monitoring Provider Dexcom's Stock Drops 40% as Q2 Revenue Misses Estimates, Lowers Full-Year Guidance

Dexcom's stock plunged nearly 40 after the company reported second-quarter revenue that missed estimates and lowered its full-year guidance.

User: Benzinga

Views: 2.3K

Uploaded: 2024-07-26

Duration: 00:37

Your Page Title